Subscribe free

HPB & Spleen ·

Hepatectomy with Bile Duct Resection Hinders Adjuvant Chemotherapy in Biliary Tract Cancer Patients

In a retrospective analysis of 168 biliary tract carcinoma patients post-surgery, 83.9% received adjuvant chemotherapy, while 16.1% did not. Notably, hepatectomy with extrahepatic bile duct resection (BDR) significantly hindered chemotherapy administration compared to other surgeries. Refractory bile leak, primarily post hepatectomy with BDR, was a common reason for non-administration. Multivariate analysis identified hepatectomy with BDR and preoperative anemia as independent factors associated with the difficulty of adjuvant chemotherapy, emphasizing the need for alternative strategies in such cases.

Journal Article by Sumiyoshi T, Uemura K (…) Takahashi S et 9 al. in Langenbecks Arch Surg

© 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

read the whole article in Langenbecks Arch Surg

open it in PubMed

Summaries are written to help you decide what to read. They do not replace the full paper.

Free · 5 minutes a day

Get every new paper in HPB & Spleen.

Plus the Daily Selection: the five most relevant papers of the day, each cut to its key points.

Specialty newsletters: every new paper in your field, as a list of titles linked to the source. Daily Selection: the five that matter, cut to their key points.

FreeNo spamOne-click unsubscribe

More in HPB & Spleen

The latest stitches

All papers in HPB & Spleen →